Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

  • There is currently no data for MIX

Interim Management Statement

5 Mar 2025 15:55

RNS Number : 5182Z
Mobeus Income & Growth VCT PLC
05 March 2025
 

MOBEUS INCOME & GROWTH VCT PLC

("the Company")

LEI: 213800HKOSEVWS7YPH79

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2024

 

Mobeus Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 31 December 2024. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 31 December 2024

(unaudited)

At 30 September 2024

(audited)

Net assets attributable to shareholders

£185.81 million

£144.32 million

Shares in issue

341,353,548

263,853,060

Net asset value (NAV) per share

54.43 pence

54.70 pence

Cumulative dividends paid

170.30 pence

170.30 pence

Cumulative Total return (net asset value basis) per share since inception

224.73 pence

225.00 pence

 

The NAV per share has decreased by 0.27 pence in the quarter (a decrease of 0.5% from the NAV per share at 30 September 2024).

 

INVESTMENT ACTIVITY DURING THE PERIOD

New Investment during the period

On 28 October 2024, the Company completed a new investment of £0.42 million into Mobility Mojo (UK) Limited, a software platform supporting accessibility audits.  

 

On 12 November 2024, the Company completed a new investment of £0.97 million into Gentianes Solutions Limited (trading as Much Better Adventures), an adventure travel marketplace.

 

Further Investments during the period

On 18 November 2024, a follow on investment of £0.27 million was made into Branchspace Limited, a digital retail software provider to the aviation and travel industry.

 

On 18 December 2024, a follow on investment of £0.46 million was made into Preservica Limited, a seller of proprietary digital archiving software.

 

On 20 December 2024, a follow on investment of £0.10 million was made into FocalPoint Positioning Limited, a GPS enhancement software provider.

 

Realisations during the period

 

Following the sale of Master Removers Group 2019 Limited (trading as Anthony Ward Thomas, Bishopsgate and Aussie Man & Van) in February 2024, a further £0.68 million was received in October 2024. The multiple on cost over the life of this investment was 3.3x.

 

FUNDRAISING

 

On 2 September 2024, the Company launched an Offer for Subscription of £45 million (including over-allotment amounts), alongside Offers from The Income & Growth VCT Plc. The Company received subscriptions amounting to the full amount and was subsequently then closed to further applications. In accordance with the Offers' prospectus, an allotment of 56,023,733 Ordinary shares took place on 1 October 2024 raising net funds (after costs) of £31.42 million for the Company and on 28 October 2024, a second allotment of 21,476,755 Ordinary Shares took place for net funds raised (after costs) of £12.05 million.

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

Further Investments after the period end

On 27 January 2025, the Company completed a follow on investment of £0.08 million into Orri Limited, an intensive day care provider for adults with eating disorders.

 

SHARE BUYBACK AFTER THE PERIOD END

On 20 January 2025, the Company purchased 3,391,695 of its own ordinary shares at a price of 51.97 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

DIVIDEND DECLARED AFTER THE PERIOD END

On 5 March 2025, an interim dividend of 2.00 pence per share in respect of the year ending 30 September 2025 was declared and will be paid on 11 April 2025 to all Shareholders whose names were on the register on 13 March 2025. Payment of this interim dividend will reduce NAV per share (shown above) to 52.43 pence and increase cumulative dividends paid to 172.30 pence per share.

 

For the first time for the Company, Shareholders can now register for the Dividend Investment Scheme ("DIS") which will allow Shareholders to receive additional shares in the Company by re-investing their total dividend payment into new shares at the latest published NAV. See the Company's website www.migvct.co.uk for further details. The dividend declared above is eligible for the DIS. Elections to join the DIS must be received by City Partnership by 26 March 2025.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSUFIIEISELD
Date   Source Headline
11th Sep 20203:30 pmRNSHalf-year Report
7th Sep 20207:00 amRNSRealisation of Investment
17th Aug 20207:30 amRNSRealisation of Investment
2nd Jul 20209:16 amRNSTransaction in Own Shares
14th May 20202:30 pmRNS1st Quarter Results
12th May 20203:45 pmRNSResult of AGM
29th Apr 20201:00 pmRNSRevised Annual General Meeting Arrangements
15th Apr 202011:00 amRNSTransaction in Own Shares
7th Apr 20207:48 amRNSAnnual Financial Report
2nd Apr 20205:10 pmRNSIssue of Equity
2nd Apr 202010:00 amRNSDividend Declaration
30th Mar 202012:40 pmRNSPublication of Suppl.Prospcts
27th Mar 20207:00 amRNSNet Asset Value(s)
19th Mar 202012:00 pmRNSDirector Declaration - Non-Executive Appointment
25th Feb 20203:15 pmRNSPublication of Suppl.Prospcts
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
7th Feb 20206:40 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:37 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:36 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:34 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:30 pmRNSPublication of Suppl.Prospcts
3rd Feb 202011:30 amRNSTotal Voting Rights
8th Jan 20204:31 pmRNSFundraising Update
8th Jan 20204:20 pmRNSIssue of Equity & Total Voting Rights
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
13th Dec 20195:50 pmRNSDividend Declaration
12th Dec 201912:40 pmRNSTransaction in Own Shares
19th Nov 201912:00 pmRNSFundraising Update
6th Nov 20195:20 pmRNS3rd Quarter Results
6th Nov 20195:00 pmRNSDividend Declaration
25th Oct 20194:00 pmRNSPublication of a Prospectus
11th Oct 20193:00 pmRNSResult of Meeting
1st Oct 201912:20 pmRNSTotal Voting Rights - Correction
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSNotice of GM
10th Sep 20195:00 pmRNSFundraising Update, Circular and General Meetings
19th Aug 201911:10 amRNSNational Storage Mechanism - Half Year Report
13th Aug 201910:20 amRNSHalf-year Report
31st Jul 20197:00 amRNSReduction of Capital
29th Jul 201911:00 amRNSShare buyback policy objective
29th Jul 20197:00 amRNSIntention to launch offers for subscription

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.